Answer
Women of childbearing potential must use appropriate contraception throughout panitumumab (Vectibix) treatment and for 2 months after the last dose.
Sources for this answer
- Vectibix 20 mg/mL concentrate for solution for infusionAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 27Document updated
Sources checked